Novo Nordisk Shares Plunge on Insulin's FDA Failure

Feb. 11 (Bloomberg) -- Bloomberg's Caroline Hyde reports that Novo Nordisk shares have fallen the most in a decade as the company's new insulin drug Tresiba has failed to win FDA approval in the United States. She speaks on Bloomberg Television's "The Pulse."
Apple Partners Up With Cisco on Corporate Networks
24:17 - Apple Inc. is teaming up with Cisco Systems Inc. to make its mobile devices work better with corporate networks using Cisco’s equipment, part of a push by Apple to expand sales to business customers. Bloomberg's Cory Johnson reports on "Bloomberg Markets." (Source: Bloomberg)
  • Storm Stalls Puerto Rico Debt Plan
  • Hedge-Fund Billionaire Bill Ackman Sponsors Tennis Star
  • Judge Could Rule on 'Deflategate' Battle Tuesday